Urogen's Chief Medical Officer Insider Trade: 400K Sale Insights
A high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
Index funds distribute capital gains at occasional dates; knowing when helps you coordinate withdrawals and tax planning effectively.
25,550 articlesA high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
Sunrun’s stock tumbled on a day of mixed signals: strong quarterly revenue but cautious guidance for 2026. This artic...
Investors are flocking to space names as Rocket Lab reports a record quarter and solid Q2 guidance. Here’s what this ...
Oil services stocks are reviving as supply constraints and geopolitical tensions push demand for drilling services hi...
Two software powerhouses offer very different paths: a hospitality-focused platform and a broad CRM suite. This guide...
Biotech stocks can swing on clinical data and regulatory news. This guide digs into whether crispr therapeutics stock...
Bitcoin nudges toward the 85K mark as institutional flows restart and inflation data stirs volatility. The bitcoin (b...
Bitcoin faces renewed pressure around the $60,000 zone with on-chain data suggesting more coins moving to exchanges. ...
Visa reports solid growth as it guards a $700 billion payments empire against threats from real-time rails and crypto...
Investors chase the next big AI champion. This piece breaks down how a single AI stock could grow into a trillion-dol...
Nvidia stock has hit a new all-time high as AI demand accelerates. This article breaks down the drivers behind the ra...
A wall street analyst thinks Viking Therapeutics could unlock substantial upside if VK2735 delivers in Phase 3. Learn...